| |
| |
|
| Insider
Information: |
Luo Mary Z. |
| Relationship: |
COO,Chief Scientist & ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,433,554 |
|
|
Indirect Shares
|
8,057,435 |
|
|
| Direct
Value |
$102,574,301 |
|
|
|
Indirect Value
|
$339,620,885 |
|
|
| Total
Shares |
10,490,989 |
|
|
| Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-15 |
4 |
D |
$14.19 |
$136,125 |
I/I |
(9,593) |
1,389,429 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-15 |
4 |
D |
$14.19 |
$385,670 |
D/D |
(27,179) |
2,120,137 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-16 |
4 |
D |
$13.03 |
$337,125 |
D/D |
(25,873) |
2,094,264 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
152,724 |
2,246,988 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-16 |
4 |
D |
$13.03 |
$101,256 |
I/I |
(7,771) |
1,381,658 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
68,303 |
1,449,961 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
• • • |
2021-03-15 |
4 |
D |
$19.15 |
$183,687 |
I/I |
(9,592) |
1,440,369 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, COB |
• • • |
2021-03-15 |
4 |
D |
$19.15 |
$537,885 |
D/D |
(28,088) |
2,218,900 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2021-03-16 |
4 |
D |
$18.44 |
$465,444 |
D/D |
(25,241) |
2,193,659 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2021-03-16 |
4 |
D |
$18.44 |
$163,932 |
I/I |
(8,890) |
1,431,479 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2021-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
56,892 |
1,488,371 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2021-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
127,209 |
2,320,868 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
76,914 |
2,397,782 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-15 |
4 |
D |
$34.74 |
$512,728 |
D/D |
(14,759) |
2,383,023 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
32,412 |
1,520,783 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-15 |
4 |
D |
$34.74 |
$166,266 |
I/I |
(4,786) |
1,515,997 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-16 |
4 |
D |
$34.22 |
$356,778 |
I/I |
(10,426) |
1,505,571 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-16 |
4 |
D |
$34.22 |
$863,747 |
D/D |
(25,241) |
2,357,782 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-17 |
4 |
D |
$34.18 |
$538,950 |
D/D |
(15,768) |
2,342,014 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-17 |
4 |
D |
$34.18 |
$241,037 |
I/I |
(7,052) |
1,498,519 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-16 |
4 |
AS |
$35.58 |
$2,433,457 |
D/D |
(68,069) |
2,273,945 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-17 |
4 |
AS |
$35.74 |
$1,801,440 |
D/D |
(50,376) |
2,223,569 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-18 |
4 |
AS |
$33.97 |
$2,289,101 |
D/D |
(67,046) |
2,156,523 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-19 |
4 |
AS |
$33.76 |
$1,408,761 |
D/D |
(41,730) |
2,114,793 |
0 |
% |
|
170 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
